Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
October 23, 2018
Patent Application Number
15489514
Date Filed
April 17, 2017
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to variants of herpes simplex virus (HSV) that selectively infect and replicate in cancer cells, including HSV strains that selectively infect and replicate in bladder cancer cells. Preferred HSV of the invention have intact endogenous Us11 and Us12 genes and have genes encoding ICP34.5 replaced with a gene encoding Us11 fused to an HSV immediate early (IE) promoter. The variant HSV of the invention also comprise one or more additional heterologous genes encoding immunomodulatory polypeptides. Methods and compositions using these variant HSV, for example, for treating cancer in a subject, are also provided.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
